Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in HCV-Related Thrombocytopenia
NCT01355289Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in Thrombocytopenia, sponsored by Eisai Co., Ltd.. Started Nov 2011; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01355289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355289.